IMRX
USDImmuneering Corporation Class A Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$6.210
고가
$6.730
저가
$6.150
거래량
0.05M
기업 기본 정보
시가총액
403.5M
산업
생명공학
국가
United States
거래 통계
평균 거래량
1.87M
거래소
NGM
통화
USD
52주 범위
관련 뉴스
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
- New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – - Conference call scheduled for Wednesday, November 12, 2025, at
Leerink Partners Initiates Coverage On Immuneering with Outperform Rating, Announces Price Target of $15
Leerink Partners analyst Andrew Berens initiates coverage on Immuneering with a Outperform rating and announces Price Target of $15.
관련 주식
ACGLN
Arch Capital Group Ltd. Depositary Shares each Representing a 1/1000th Interest in a 4.550% Non-Cumulative Preferred Share Series G
TEI
Templeton Emerging Markets Income Fund Inc.
WTM
White Mountains Insurance Group Ltd.
KMT
Kennametal Inc.
MSB
Mesabi Trust
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기